"I have epilepsy," the boy said. "Do you think I'll ever have a girlfriend?" Kill paused for a moment, and looked around the room. It was one of many epilepsy questions Kill would face in 2012. It was perhaps the most poignant question, but not the toughest. The toughest would come months after the child raised his hand, well into the Gophers' season, after Kill had seizures during games and missed a half of football against Michigan State. Some of those questions would be asked to his face, and some behind his back. What does it feel like when you have a seizure? Is it the stress from coaching? Won't recruits be scared off? Isn't this too much of a distraction for the program? Might you die on the field? Are you fit to coach this team? Kill is still surprised by all of this. He had his first seizure 12 years ago. He's had many since. They are a part of his life. In fact, they are a reason for his life. One of his seizures brought him to the hospital, where doctors did tests and found out he had kidney cancer. If he didn't have the epilepsy, maybe … Continue reading →

NEW YORK, Dec. 26, 2012 /PRNewswire/ --Scientists from Beth Israel Medical Center and the Icahn School of Medicine at Mount Sinai have announced the discovery of a novel gene for primary torsion dystonia, a debilitating neurological disorder estimated to affect no fewer than 300,000 people in the US and Canada. Published online December 9 in Nature Genetics, the findings describe the GNAL gene, the first primary torsion dystonia gene that directly points to pathways in the brain's dopamine system as the origin of pathophysiology. Genetic study in two extensively studied dystonia families revealed mutations in GNAL. Further screening of 39 additional affected families identified another six mutations in this gene. The research unveils a new potential therapeutic target and thus an opportunity for developing new treatments. This discovery will also help development of genetic tests to confirm diagnosis, identify unaffected adult carriers, and provide greater reproductive health options for affected families. The discovery was made through the collaboration of a clinical research team of movement disorder specialists in the United States and Canada led by Susan Bressman, MD, Chair of the Mirken Department of Neurology at Beth Israel Medical Center and the work of the molecular genetic laboratory at the … Continue reading →

World Stem Cells Clinic's newly constructed state-of-the art laboratory at the Tulum Trade Center in Cancun. World Stem Cells Clinic's research, protocols and team approach, maximizes patient's benefits from stem cell treatments. (PRWEB) December 27, 2012 World Stem Cells Clinic's research has developed the best protocols to maximize patients benefit from stem cell treatments, operating under the stringent guidelines as established by The International Cellular Medical Society (ICMS) and the US Federal Drug Administrations Good Tissue Practice (cGTP) regulations for pharmaceutical, biologics and clinical laboratories. World Stem Cells Clinic's strict adherence to these established guidelines and policies guarantees the highest quality of clinical care and stem cell treatment safety for you. The patients are enrolled in a United States open registry to track their changes independently, for up to 20 years. The staff physicians at World Stem Cells Clinic are all board certified, in their field with years of experience. Dr. Sylvia Abblitt is a Board Certified Hematologist & Oncologist, her practice began in 1984 and is a member of the ICMS ( International Cellular Medical Society), with 20+ years in treating multiple types of diseases with stem cells. Dr. Alan Kadish both Allopathic and Naturopathic with 26 years as … Continue reading →

Frank Farmer has come on board with World Stem Cell Institute, Inc. after his son Kell's stem cell treatment and was amazed at his son's progress. Frank has become an advocate for the use of Stem Cell Treatment(SCT) for other qualified children with ASD along with promoting and aiding World Stem Cell Institute, Inc. to complete clinical trials for preemie babies and other diseases. Tampa, FL (PRWEB) December 27, 2012 Kell's video: http://www.youtube.com/embed/O7PSi7Qt5h8 Kell's story:http://worldstemcells.com/kell-stem-cell-treatment-for-autism.html World Stem Cell Institute, Inc will educate the general public about stem cell and ethical use in general, diseases and potential benefit of a stem cell treatment through publishing an on-going research on stem cells clinical trials. Frank Farmer said he is dedicated to promoting and aiding World Stem Cell Institute, Inc. to achieve its goals for 2013 to provide financial assistance to a minimum of 20 patients who would benefit from a stem cell treatment but do not have the funds required while undergoing a stem cell treatment, to complete clinical trials such as the Preemie clinical trial that would help prevent blindness and other disease in premature babies with the use of stem cells from the lab of World Stem Cells Clinic or … Continue reading →